IBN
NEUTRALAt a glance
Key valuation, profitability, growth, and risk metrics.
AI Analysis
AI-powered fundamental assessment
Key Strengths
Key Risks
Performance Snowflake
Multi-dimensional analysis across 5 key categories
P/E of 17.32 is reasonable for the sector, and PEG suggests significant growth upside.
- PEG ratio 0.52
- Price below Intrinsic Value ($31.16)
- Price above Graham Number ($19.62)
Growth metrics are the primary bullish driver for this asset.
- 66.9% YoY Revenue Growth
- Positive Q/Q earnings progression
- Earnings growth lagging significantly behind revenue growth
Long-term trajectory is positive, but short-term momentum is severely impaired.
- Positive 5Y change (+69.8%)
- Negative 1Y (-17.2%) and 6M (-11.5%) returns
The F-Score indicates a failure in most fundamental health checkpoints.
- Stable profit margins (24.93%)
- Piotroski F-Score of 2/9 is critically low
Dividend is a negligible factor for total return but is fundamentally safe.
- Low payout ratio (14.69%) ensures safety
- Very low yield (0.90%)
Stock Price & Analyst Targets
Real-time price movements and analyst price targets
Multi-Horizon Performance vs Peers
Price momentum across 5Y → 1W horizons for IBN and closest competitors.
| Company | 5Y | 3Y | 1Y | 6M | 1M | 1W |
|---|---|---|---|---|---|---|
|
IBN
ICICI Bank Limited
Primary
|
+69.8% | +24.1% | -17.2% | -11.5% | +8.8% | -4.2% |
|
BMO
Bank of Montreal
Peer
|
+120.0% | +57.5% | +42.1% | +21.6% | +5.5% | +0.9% |
|
CM
Canadian Imperial Bank of Commerce
Peer
|
+164.8% | +204.6% | +84.8% | +34.2% | +13.4% | +0.2% |
|
CME
CME Group Inc.
Peer
|
+107.0% | +88.5% | +33.3% | +4.1% | +6.3% | +3.1% |
|
BNS
The Bank of Nova Scotia
Peer
|
+76.6% | +68.7% | +49.2% | +32.2% | +1.1% | +1.9% |
Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.
Historical Performance Trends
Long-term financial metrics and growth patterns
Revenue & Net Income
Profit & Operating Margins
Return on Equity (ROE)
Quarterly Revenue Growth
Valuation Metrics
Key valuation ratios and pricing indicators
Profitability
Profit margins and return metrics
Growth
Revenue and earnings growth rates
Financial Health
Balance sheet strength and liquidity metrics
Financial Statement Flow
Interactive flow visualization showing how money moves through the company Q1 2026
Quarterly Earnings History
EPS performance vs analyst estimates
Financial Services Sector Comparison
Similar Companies
Peer comparison within the same industry
| Company | AI Rating | Market Cap | P/E | ROE | Profit Margin | Price | |
|---|---|---|---|---|---|---|---|
|
IBN
ICICI Bank Limited
|
NEUTRAL | $98.66B | 17.32 | 16.4% | 24.9% | $27.54 | |
|
BMO
Bank of Montreal
|
NEUTRAL | $98.97B | 16.77 | 10.1% | 26.7% | $137.69 | Compare |
|
CM
Canadian Imperial Bank of Commerce
|
NEUTRAL | $100.8B | 15.6 | 14.7% | 33.5% | $109.52 | Compare |
|
CME
CME Group Inc.
|
NEUTRAL | $102.78B | 27.62 | 13.3% | 58.9% | $285.04 | Compare |
|
BNS
The Bank of Nova Scotia
|
NEUTRAL | $93.29B | 18.17 | 9.0% | 24.6% | $74.87 | Compare |
SEC Filings
Recent regulatory filings from the SEC EDGAR database
IBN filed its Form 20-F annual report on July 25, 2025, providing a comprehensive disclosure of its fiscal year financial performance and operational risks. Due to the limited information provided, specific financial highlights and risk factors are not detailed, but the filing serves as the primary regulatory update for this foreign private issuer.
Past News Coverage
Recent headlines mentioning IBN from our newsroom.